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Abstract
Background: Wnt signaling affects fundamental development pathways by regulating cell
proliferation and differentiation. Aberrant activation of Wnt/β-catenin signaling promotes the
development of several cancers and is an attractive target for chemopreventive and
chemotherapeutic agents.
Results: In order to identify the novel antagonists for the Wnt/β-catenin pathway, we employed
a cell-based Wnt reporter system (TOPflash) to screen a library of 960 known drugs. We identified
spiperone, a psychotropic drug, as a novel Wnt inhibitor, which specifically blocks canonical Wnt
signaling prior to the activation of β-catenin. The Wnt inhibitory function of spiperone is not
associated with its dopamine-, serotonin- and sigma-receptor antagonist properties. Instead,
spiperone increases intracellular calcium levels in a similar manner to thapsigargin, that also
impedes Wnt signal transduction. Inhibition of protein kinase C had no effect on spiperone-
mediated antagonism of Wnt signaling.
Conclusion: Spiperone is a calcium regulator. It inhibits Wnt signaling by enhancing intracellular
calcium levels.
Background
The Wnt signaling pathway plays important roles in the
regulation of cell proliferation, differentiation, and apop-
tosis [1-4]. In the canonical Wnt pathway, Wnt initiates
signaling events by binding to a receptor complex, con-
sisting of a member of the Frizzled (Fzd) family, and the
low-density lipoprotein-receptor-related proteins (LRP) 5
or LRP6. Subsequently the cytoplasmic adaptor protein
disheveled (Dvl) is phosphorylated and inhibits glycogen
synthase kinase (GSK)-3β activity through its association
with axin. Unphosphorylated β-catenin accumulates in
the cytoplasm and translocates into the nucleus, where it
interacts with members of T cell factor/lymphoid
enhancer factor (TCF/LEF) family to activate transcription
of Wnt target genes [1-4].
The β-catenin molecule is a key effector in the canonical
Wnt pathway. However, not all Wnt proteins activate the
β-catenin complex. Some Wnt family members, such as
Wnt4, Wnt5a and Wnt11, are able to initiate β-catenin-
independent Wnt signaling by binding to a Frizzled recep-
tor and possibly the coreceptor, Knypek (Kny) or Ror1 or
Ror2 [5,6]. This leads to release of intracellular calcium
and the activation of enzymes such as calcium/calmodu-
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kinase C (PKC), which exert antagonistic activity on the
canonical Wnt pathway. Calcium has been implicated as
an important mediator of antagonism of canonical Wnt
signaling, acting at multiple points in the canonical Wnt
pathway [5,7,8].
Spiperone is a butyrophenone antipsychotic agent with
dopamine and serotonin (5-HT) receptor antagonist
properties [9-11]. It is also a high affinity ligand of sigma
receptors [12]. Radiolabeled spiperone and its analogues
have been widely used in assessing dopamine receptor
function based on positron emission tomography (PET)
in humans. In this study, we demonstrate that spiperone,
but not other related psychotropic drugs blocks canonical
Wnt signaling activated by Wnt and LRP6 by elevating
intracellular calcium levels.
Results
Inhibition of canonical Wnt signaling by spiperone
To identify antagonists of canonical Wnt signaling, we
used a cell-based TOPflash reporter system to screen the
Gen-plus drug library (Microsource) that contains 960
FDA-approved drugs. In this system, transfected Dvl (an
upstream activator of the Wnt pathway) stimulated TCF/
LEF response elements in the TOPflash reporter gene.
Inhibitors of Wnt signaling were identified based on their
ability to block the transcription of the reporter gene, but
not a control gene. Small molecular compounds were
screened at 10 μM and 50 μM. The initial screen identified
spiperone as an antagonist of Wnt signaling. To confirm
the Wnt inhibitory effect of spiperone, the TOPflash
reporter was activated by Wnt1/LRP6 or Wnt3/LRP6, Dvl
and β-catenin, respectively, in transient transfection
assays. Treatment with 5 μM spiperone only weakly inhib-
ited Dvl- or β-catenin-mediated signaling (Figure.
1B&1C), whereas a more potent effect was observed at
higher concentration (≥ 10 M) (data not shown). Surpris-
ingly, treatment of the same dose of spiperone strongly
blocked Wnt signaling activated by Wnt1/LRP6 and
Wnt3/LRP6, respectively (Figure 1A). In control experi-
ments, spiperone did not inhibit signals from reporter
genes for NFAT and activator protein 1 (AP-1) (Figure 1D
&1E). These results suggest that spiperone may specifically
inhibit Wnt signaling by targeting the Wnt/LRP complex.
Spiperone was chosen for the further study because of its
highly selective inhibitory effect on Wnt/LRP-mediated
signaling.
Antipsychotic spiperone analogs have no inhibitory effect 
on Wnt signaling
To determine whether spiperone-mediated inhibition of
Wnt signaling is associated with its antipsychotic effect,
we examined other psychotropic drugs for their effects on
Wnt signaling. These ligands include serotonin 5-HT1
receptor antagonists (pindolol, UH-301, WAY100635
and NAN-190), 5-HT1 receptor agonist (8-OH-DPAT), 5-
HT2 receptor antagonists (ketaserin and SB-204741),
additional serotonin receptor antagonists (clozapine and
SB-269970) and a sigma receptor ligand (DTG) [13-15].
NAN-190 and clozapine have been shown to be
dopamine receptor antagonists, whereas UH-301 and
WAY100635 are dopamine receptor agonists [16,17].
The TOPflash reporter was transfected into HEK293 cells
with expression plasmids for Wnt1 and LRP6. The cells
were treated with increasing concentrations of the various
psychotropic drugs. Surprisingly, none of the drugs tested
except spiperone had the ability to block Wnt1/LRP6-
mediated signaling (Figure. 2), suggesting that inhibition
of Wnt signaling is not related to compound interactions
with dopamine, serotonin or sigma receptors.
Spiperone displays a similar Wnt inhibition profile to that 
of ionomycin and thapsigargin
A previous study demonstrated that ionomycin strongly
inhibited Wnt pathway activation induced by a Wnt lig-
and, but had much less effect on β-catenin-mediated Wnt
signaling [7]. The inhibition profile exerted by ionomycin
treatment is similar to that of spiperone. Accordingly, we
examined the Wnt inhibitory effects of spiperone, iono-
mycin and thapsigargin. Ionomycin and thapsigargin are
well known agents that mobilize intracellular calcium. As
shown in Figure 3, all three agents dramatically inhibited
Wnt signaling activated by Wnt1 and LRP6. In contrast,
spiperone and thapsigargin weakly inhibited Dvl-medi-
ated signaling, whereas ionomycin had almost no inhibi-
tory effect at the concentration tested (Figure. 3). We
observed some inhibition in Dvl-mediated transcription
at higher drug concentrations, associated with cell toxicity
(data not shown). These results suggest that spiperone,
ionomycin and thapsigargin inhibit the Wnt signaling
pathway through a similar mechanism, that involves
changes in intracellular calcium levels.
Spiperone effects on calcium mobilization
In order to assess whether spiperone has the ability to ele-
vate intracellular calcium levels, Fluo-4 FACS analysis was
used. As shown in Figure 4A, spiperone and ionomycin
increased intracellular calcium levels, whereas DTG had
no affect under similar conditions. In cells treated with
ionomycin, calcium levels remained elevated throughout
the recording period (Figure. 4A). In contrast, calcium sig-
nals induced by spiperone were relatively transient, sug-
gesting that the two drugs alter calcium concentrations by
different mechanisms. The effect of spiperone was dose-
dependent, with a maximal increase in calcium levels
occurring at 5 μM (Figure. 4B).Page 2 of 8
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across membranes by shielding its polar electrical charge
from the apolar lipid bilayer [18]. Thapsigargin is an
inhibitor of the calcium ATPase pump, which causes cal-
cium release from the endoplasmic reticulum into the
cytoplasm, leading to perturbations in calcium homeosta-
sis [19]. As expected, pretreatment with 1 μM thapsigargin
could not abolish ionomycin-induced calcium release
(Figure 4C). However, thapsigargin blocked the subse-
quent cellular calcium response to spiperone. (Figure 4D).
Similarly, pretreatment with spiperone prevented the
thapsigargin-induced calcium increase (Figure 4E). These
results suggest that spiperone and thapsigargin may act by
a similar mechanism to enhance intracellular calcium lev-
els.
The PKC inhibitor GF109203X does not affect spiperone-
mediated inhibition of Wnt signaling
Calcium is a ubiquitous second messenger used to regu-
late a wide range of cellular processes. When intracellular
calcium is increased, it interacts with protein kinase C
(PKC), calmodulin, and with other intracellular mole-
cules, to activate downstream signaling pathways. To
explore the role of PKC in spiperone-mediated inhibition
of Wnt signaling, a PKC inhibitor GF109203X was tested.
As indicated in Figure 5, GF109203X had no effect on
spiperone-mediated inhibition of Wnt signal transduc-
tion induced by Wnt1 and LRP6, while GF109203X alone
slightly enhanced the Dvl-initiated signaling pathway
(Figure 5).
Inhibition of Wnt signaling by spiperoneFigure 1
Inhibition of Wnt signaling by spiperone. HEK293 cells were cotransfected with a TOPflash reporter construct, along 
with vectors for: (A) control (pcDNA3 plasmid alone), Wnt1/LRP6, or Wnt3/LRP6; (B) control (pcDNA3 plasmid alone) or 
Dvl; (C) control (pcDNA3 plasmid alone) or β-catenin. (D) HEK293 cells were transfected with an NFAT-Luc reporter and an 
expression plasmid for NFATc. (E) HEK293 cells were transfected with an AP1-Luc reporter and an expression plasmid for H-
RasV12. After transfection for 24 h, the cells were treated with or without spiperone (5 μM) for another 24 h, and then har-
vested, and extracted for determination of luciferase activities. The β-galactosidase control plasmid was used to correct for 
transfection efficiency. The results are expressed as fold induction of luciferase activity normalized to a β-galactosidase control, 
and are the means of three experiments ± SEM.Page 3 of 8
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Previous studies have demonstrated that noncanonical
Wnt family members repress canonical Wnt signaling by
inducing a calcium influx [5,7,20-22]. Some regulators of
calcium signaling also have been shown to inhibit canon-
ical Wnt signaling [23,24]. Maye et al. reported that an
increase in intracellular calcium concentration induced by
ionomycin led to inhibition of the canonical Wnt path-
way [7]. They also noted that ionomycin strongly blocked
Wnt1-activated signaling, whereas its inhibition became
much less effective with downstream pathway activators
such as Dvl and β-catenin [7]. In this study, we identified
spiperone as a calcium regulator. Like ionomycin and
thapsigargin, spiperone specifically targets the Wnt/LRP6
complex, and increases intracellular calcium levels. How-
ever, it is unclear how calcium blocks Wnt-activated sign-
aling. Our results indicate that blocking PKC activity by
GF109203X does not alter spiperone-mediated inhibition
of Wnt signaling, suggesting that the PKC activation path-
way is not involved.
Effect of psychotropic drugs on Wnt signaling activated by Wnt1 and LRP6Figure 2
Effect of psychotropic drugs on Wnt signaling activated by Wnt1 and LRP6. The TOPflash reporter was transfected 
into HEK293 cells with expression plasmids encoding Wnt1 and LRP6. After transfection, cells were treated with increasing 
concentrations of antipsychotic spiperone analogs for 24 h, as indicated. Then cells were harvested and luciferase activities 
were determined.Page 4 of 8
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lator of β-catenin/TCF signaling in colon cancer cells and
its inhibitory mechanism is related to the decreased
nuclear β-catenin products and to the suppressed binding
of TCF complexes to consensus DNA [8]. However, this
study did not check the effect of ionomycin on Wnt sign-
aling activated by Wnt and LRP coreceptor. In our experi-
ment, we showed that spiperone and thapsigargin weakly
inhibited Dvl-mediated signaling (Figure 3). We also
noted that ionomycin elicited some inhibitory effect on
Dvl- and β-catenin-mediated signaling at concentrations
equal to and above 5 μM (data not shown). Therefore, in
addition to its inhibition function on Wnt/LRP complex,
ionomycin may target multiple steps of the canonical Wnt
pathway.
Spiperone is a psychotropic agent that acts as a potent
dopamine D2, serotonin 5-HT1A, and serotonin 5-HT2A
antagonist [9-11], and binds to sigma receptors with high
affinity [12]. Spiperone also has been reported to have
immunosuppressive effects in the mouse, and this action
may be independent of its serotonin or dopamine recep-
tor blocking properties [25]. Among the several related
psychotropic drugs analyzed in the present study, only
spiperone significantly blocked Wnt signaling. It will be
interesting to determine whether spiperone-mediated
Wnt inhibition is associated with its immunosuppressive
function, insofar as Wnt-signaling is required for lym-
phocyte development.
During the preparation of this manuscript, Liang et al.
[26] reported that spiperone stimulated calcium-depend-
ent chloride secretion through a protein tyrosine kinase-
coupled phospholipase C-dependent pathway, which
supports our findings.
Conclusion
In summary, our result clearly demonstrated that spiper-
one is a calcium regulator. It specifically blocks canonical
Wnt signaling by elevating intracellular calcium levels.
This drug may have chemopreventive or chemotherapeu-




Spiperone, ionomycin, thapsigargin (Tg), pindolol, UH-
301, WAY100635, 8-OH-DPAT, SB-269970, NAN-190,
SB-204741, Ketaserin, Clozapine, DTG (1,3-di-o-tolylgua-
nidine) and GF109203X were purchased from Sigma-
Aldrich (St. Louis, MO). A Gen-plus collection of 960
known drugs was obtained from Microsource (Gaylords-
ville, CT).
Transfection and screening of drug library
The human embryonic kidney cell line HEK293 (Ameri-
can Type Culture Collection, Rockville, MD) was trans-
fected using the FuGene transfection reagent (Roche
Diagnostics GmbH, Mannheim, Germany) according to
the manufacturer's instruction.
The reporter plasmid TOPflash was a gift from H. Clevers
(University of Utrecht, Utrecht, The Netherlands). The
NFAT-Luc and AP1-Luc reporters were purchased from BD
Biosciences. The expression plasmids encoding Wnt1,
Wnt3, LRP6, Dvl, β-catenin, NFATc and H-rasV12 have
been described previously [27,28].
For screening of the drug library, HEK293 cells were
grown for at least 24 h in 10 cm plates prior to transfec-
tion. At ~50% confluence, cells were transfected with 5 μg
of TOPflash reporter, 1 μg expression vector for Dvl, 1 μg
of control plasmid pCMXβgal and carrier DNA pcDNA3
plasmid for a total of 10 μg/plate. After transfection for 24
h, cells were harvested and dispersed in 96-well microtiter
plates. Then the cells were treated with the different
agents, generally at 10 μM and 50 μM for the initial
screen. After overnight incubation, the cells were lysed in
1× potassium phosphate buffer, pH 7.8, containing 1%
Triton X-100, and luciferase activities were assayed in the
presence of substrate using a microtiter plate luminometer
(MicroBeta TriLux, Gaithersburg, MD). The luciferase val-
ues were normalized for variations in transfection effi-
ciency using the β-galactosidase internal control.
Spiperone, and other compounds that were scored posi-
tive, had ≥30% inhibition of TOPflash activity when com-
pared to the designated control cultures. In other
experiments, transient transfections were performed in
Spiperone, ionomycin and thapsigargin inhibit Wnt1- and LRP6-initiated Wnt signalingFigure 3
Spiperone, ionomycin and thapsigargin inhibit Wnt1- 
and LRP6-initiated Wnt signaling. HEK293 cells were 
transfected with a TOPflash reporter and expression plas-
mids for Wnt1, LRP6 and Dvl as indicated in the figure. After 
transfection for 24 h, cells were grown with 5 μM spiperone, 
2 μM ionomycin, 50 nM thapsigargin and vehicle control for 
another 24 h. Then luciferase values were determined.Page 5 of 8
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Spiperone induce a rise in intracellular calcium levelsFigure 4
Spiperone induce a rise in intracellular calcium levels. (A) Tracing of fluo-4 fluorescence in cells stimulated with 10 μM 
spiperone, 10 μM DTG and 2 μM ionomycin over time. Drugs were added at 30 sec. (B) Tracing of fluo-4 fluorescence in cells 
stimulated with increasing doses of spiperone. Drugs were added at 30 sec. (C) Pretreatment with 1 μM thapsigargin could not 
abolish ionomycin-induced calcium release. Drugs were added at 10 and 225 sec as indicated by the arrowheads. (D) Thapsi-
gargin blocks the subsequent cellular calcium responses to spiperone. Intracellular Ca2+ was recorded after stimulation with 1 
μM thapsigargin and 10 μM spiperone. Drugs were added at 30 and 225 sec as indicated by the arrowheads. (E) Spiperone pre-
vented thapsigargin-induced calcium increase. Intracellular calcium was traced after stimulation with 10 μM spiperone and 1 μM 
thapsigargin. Drugs were added at 30 and 225 sec as indicated by the arrowheads.
BMC Pharmacology 2009, 9:13 http://www.biomedcentral.com/1471-2210/9/1312-well plates. HEK293 cells were transfected with 0.5 μg
of reporter plasmid, 0.1 μg of control plasmid pCMXβgal,
0.1-0.2 μg expression plasmids, and carrier DNA pcDNA3
plasmid for a total of 1 μg/well. After 16 h, the cells were
washed and treated with 5 μM spiperone or solvent
(DMSO) for 24 h. Then luciferase values were determined.
In the Results section, data are expressed as fold stimula-
tion of luciferase activity compared to the basal level. All
the transfection results represent means of a minimum of
three independent transfections assayed in duplicate, ±
the standard error of the mean (SEM).
Calcium measurements
Changes in intracellular Ca2+ concentration were meas-
ured with the calcium sensitive dye Fluo-4 (Fluo-4/AM,
Molecular Probes). Briefly, HEK293 cells (2 × 106 cells/
ml) were incubated with 2 μM Fluo-4/AM at 37°C for 30
min in Hanks balanced salt solution (HBSS) containing 5
mM KCl, 0.4 mM KH2PO4, 0.8 mM MgSO4, 137 mM
NaCl, 0.3 mM Na2HPO4, 5.5 mM glucose, 1.26 mM
CaCl2, 0.5 mM MgCl2. Cells were washed 2 times with
HBSS and then suspended in 2 ml HBSS. Samples were
analyzed for 30 sec to establish a base line and then stim-
ulated with 2 μM ionomycin, 10 μM DTG, 1 μM thapsi-
gargin and different concentrations of spiperone as
indicated in figure 4. The intracellular calcium concentra-
tion was measured by flow cytometry using a FACSCali-
bur (Becton Dickinson). The calcium concentration was
expressed as Fluo-4/AM fluorescence intensity using the
FL1 channel. At least 10,000 cells were counted to evalu-
ate the intracellular calcium elevation.
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